FDA updates cybersecurity guidance for medical device makers

The Food and Drug Administration Sept. 26 finalized guidance updating the cybersecurity information device makers should submit to its Center for Devices and Radiological Health or Center for Biologics Evaluation and Research for premarket review of devices that have cybersecurity considerations. The recommendations are intended to help manufacturers meet their obligations under section 524B of the Federal Food, Drug, and Cosmetic Act, enacted in December 2022 as part of the Consolidated Appropriations Act of 2023, which defines “cyber device” as one that includes a device or software that can connect to the internet and be vulnerable to cybersecurity threats.
Related News Articles
Headline
Microsoft July 22 released an update on the ongoing cyberattacks to SharePoint servers used within organizations, attributing the incidents to China-based…
Headline
The FBI, Cybersecurity and Infrastructure Security Agency, Department of Health and Human Services, and Multi-State Information Sharing and Analysis Center…
Headline
Microsoft July 19 issued an alert about active attacks from vulnerabilities targeting SharePoint servers used within organizations. The incidents have not…
Headline
In his latest AHA Cyber and Risk Intel blog, Scott Gee, AHA deputy national advisor for cybersecurity and risk, explains how hospitals can prepare for and…
AHA Cyber Intel
In today’s heightened threat environment, driven by domestic and geopolitical issues, it is more critical than ever for hospitals to prepare for and mitigate…
Headline
In a statement submitted to the Senate Health, Education, Labor and Pensions Committee for a hearing today on health care cybersecurity and patient privacy,…